Clinical and Epidemiologic Profile of Cutaneous Leishmaniasis in Colombian Children: Considerations for Local Treatment
Open Access
- 7 August 2013
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 89 (2) , 359-364
Abstract
Treatment alternatives have seldom been evaluated in children with cutaneous leishmaniasis (CL). We examine the clinical/epidemiological profile of children with CL considering international guidelines for local treatment. Descriptive analyses were conducted using International Center for Medical Research and Training (CIDEIM) case reports of parasitologically diagnosed patients ≤ 14 years of age from 2004 to 2010. Eligibility for local treatment based on World Health Organization/Pan American Health Organization (WHO/PAHO) criteria was determined. Among 380 children, 90% presented lesions of < 3 months duration, 54% presented single lesions < 30 mm in diameter, and 45% were ≤ 5 years old. Lesions on the head and neck were more frequent among children 0–5 years, and lesions below the head/neck were more frequent among 11- to 14-year-old children (P = 0.004). Using PAHO and WHO criteria, 26% and 53% of children, respectively, were eligible for local treatment. Recommended local treatments for New World CL have potential but limited applicability in children. Individual risk–benefit assessment and effectiveness data in children may increase eligibility.Keywords
This publication has 32 references indexed in Scilit:
- Topical Paromomycin with or without Gentamicin for Cutaneous LeishmaniasisNew England Journal of Medicine, 2013
- Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.Trials, 2012
- Noninferiority of Miltefosine Versus Meglumine Antimoniate for Cutaneous Leishmaniasis in ChildrenThe Journal of Infectious Diseases, 2012
- Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, BrazilThe American Journal of Tropical Medicine and Hygiene, 2011
- Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled TrialPLOS Neglected Tropical Diseases, 2010
- Viability and Burden of Leishmania in Extralesional Sites during Human Dermal LeishmaniasisPLOS Neglected Tropical Diseases, 2010
- A Randomized Controlled Trial of Local Heat Therapy Versus Intravenous Sodium Stibogluconate for the Treatment of Cutaneous Leishmania major InfectionPLOS Neglected Tropical Diseases, 2010
- WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled StudyPLOS Neglected Tropical Diseases, 2009
- Detection ofLeishmaniaDNA by Polymerase Chain Reaction in Scars of Treated Human PatientsThe Journal of Infectious Diseases, 1998
- Cutaneous leishmaniasis in western Venezuela caused by infection with Leishmania venezuelensis and L. braziliensis variantsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992